Dow Jones Hangs On While Memory Chips Take Another Beating
2026-07-16 17:03
•Anders Bylund •The Motley Fool
••••••• ••••••••••••• Axe Capital view
Semiconductor Selloff Tests Tech, Rand Steadies
Higher chipmaker spending weighs on global tech, but the rand holds firm amid stable financials.
Taiwan Semiconductor’s surprise capital expenditure hike highlights the semiconductor industry's tough balancing act: growth versus profitability. Memory chip players like SK Hynix and Micron, more sensitive to cyclical demand swings, have suffered sharp share price drops. This chip selloff dragged the Nasdaq down, while the Dow leaned on healthcare giants UnitedHealth and Abbott for stability. For South African investors, the tech weakness in the US hints at caution for Prosus and Naspers, which have significant US tech exposure. Meanwhile, the rand’s relative calm versus the dollar suggests local financials—like Standard Bank and FirstRand—may better weather global tech shocks for now. But if global chip demand slows substantially, expect some pressure on foreign earnings repatriated by SA tech stocks. The key question is whether the sector’s capital spending will translate to longer-term AI-driven growth or just margin erosion for now. I lean towards caution given current uncertainty but remain alert. this is just my opinion and not financial advice
Trim exposure to Prosus and Naspers as US tech softness persists, and watch Standard Bank and FirstRand for a more defensive stance. Avoid memory chip plays directly due to profitability risks.
- Prosus
- Naspers
- Standard Bank
- USD/ZAR
- Memory chip demand falls faster than expected
- Rand weakens sharply due to global risk-off
6/10
The semiconductor sector continued its fourth consecutive day of losses after Taiwan Semiconductor raised capital expenditure forecasts to $60-64 billion, sparking investor concerns about profitability. Memory chip stocks like SK Hynix and Micron plummeted, dragging down the Nasdaq and S&P 500. The Dow remained relatively stable as healthcare stocks, particularly UnitedHealth and Abbott Laboratories, rallied on strong earnings, offsetting tech sector weakness.
This article was originally published by The Motley Fool and has been adapted here for Axe Capital Trading News.
Publisher: The Motley Fool
Author: Anders Bylund
Categories: Equities, Earnings, IPOs, Technology, AI, Semiconductors, Healthcare
Tickers: TSM, SKHY, MU, NVDA, AVGO, GS, GSPA, GSPC, GSPD, CAT, UNH, ABT, SPCX
Sentiment: Mixed - Stock fell 4.6% despite beating earnings estimates due to significantly increased capital expenditure guidance ($60-64B vs prior $52-56B), raising investor concerns about spending sustainability and profitability. Plunged 9.1% on Thursday, extending losses to roughly 30% from recent post-IPO highs, reflecting broader semiconductor sector weakness and investor concerns about memory chip demand.
Keywords: semiconductor sell-off, capital expenditures, memory chips, tech stocks decline, healthcare rally, earnings season, AI demand
Insights:
- TSM: Negative: Stock fell 4.6% despite beating earnings estimates due to significantly increased capital expenditure guidance ($60-64B vs prior $52-56B), raising investor concerns about spending sustainability and profitability.
- SKHY: Negative: Plunged 9.1% on Thursday, extending losses to roughly 30% from recent post-IPO highs, reflecting broader semiconductor sector weakness and investor concerns about memory chip demand.
- MU: Negative: Dropped 6.3% as part of the semiconductor sector selloff triggered by Taiwan Semi's capital expenditure announcement and broader concerns about chip industry profitability.